These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16174538)

  • 1. Cidofovir for recurrent respiratory papillomatosis (RRP): a re-assessment of risks.
    Derkay C;
    Int J Pediatr Otorhinolaryngol; 2005 Nov; 69(11):1465-7. PubMed ID: 16174538
    [No Abstract]   [Full Text] [Related]  

  • 2. Scientific and clinical aspects of the use of cidofovir in recurrent respiratory papillomatosis.
    Donne AJ; Rothera MP; Homer JJ
    Int J Pediatr Otorhinolaryngol; 2008 Jul; 72(7):939-44. PubMed ID: 18502519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic cidofovir in papillomatosis.
    Van Valckenborgh I; Wellens W; De Boeck K; Snoeck R; De Clercq E; Feenstra L
    Clin Infect Dis; 2001 Feb; 32(3):E62-4. PubMed ID: 11170974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degrees of dysplasia and the use of cidofovir in patients with recurrent respiratory papillomatosis.
    Gupta HT; Robinson RA; Murray RC; Karnell LH; Smith RJ; Hoffman HT
    Laryngoscope; 2010 Apr; 120(4):698-702. PubMed ID: 20205173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cidofovir modulated gene expression in recurrent respiratory papillomatosis.
    Poetker DM; Patel NJ; Kerschner JE
    Int J Pediatr Otorhinolaryngol; 2008 Sep; 72(9):1385-92. PubMed ID: 18620760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Society of Pediatric Otolaryngology members' experience with recurrent respiratory papillomatosis and the use of adjuvant therapy.
    Schraff S; Derkay CS; Burke B; Lawson L
    Arch Otolaryngol Head Neck Surg; 2004 Sep; 130(9):1039-42. PubMed ID: 15381589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature.
    Shehab N; Sweet BV; Hogikyan ND
    Pharmacotherapy; 2005 Jul; 25(7):977-89. PubMed ID: 16006276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cidofovir efficacy in recurrent respiratory papillomatosis: a randomized, double-blind, placebo-controlled study.
    McMurray JS; Connor N; Ford CN
    Ann Otol Rhinol Laryngol; 2008 Jul; 117(7):477-83. PubMed ID: 18700421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cidofovir: to use or not to use?
    Soma MA; Albert DM
    Curr Opin Otolaryngol Head Neck Surg; 2008 Feb; 16(1):86-90. PubMed ID: 18197029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intralesional cidofovir injection for recurrent respiratory papillomatosis in Japan.
    Murono S; Nakanishi Y; Tsuji A; Endo K; Kondo S; Wakisaka N; Yoshizaki T
    Auris Nasus Larynx; 2016 Oct; 43(5):541-5. PubMed ID: 26860235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degrees of dysplasia based on viral typing in patients with cidofovir use and recurrent respiratory papillomatosis.
    Moore JE; Garcia A; Sanyal S; Saunders S; Portnoy JE; Hu A; Sataloff RT
    J Voice; 2013 Nov; 27(6):765-8. PubMed ID: 24128893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should intralesional cidofovir be used for recurrent respiratory papillomatosis?
    Donne A; Rothera M; Homer J
    Clin Otolaryngol; 2010 Feb; 35(1):60. PubMed ID: 20447168
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential risk factors associated with the use of cidofovir to treat benign human papillomavirus-related disease.
    Donne AJ; Hampson L; He XT; Day PJ; Salway F; Rothera MP; Homer JJ; Hampson IN
    Antivir Ther; 2009; 14(7):939-52. PubMed ID: 19918098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel method of intralesional cidofovir injection into laryngotracheal papillomata.
    Sahota RS; Uddin FJ; Al-Shukri J; Moir AA
    J Laryngol Otol; 2011 Apr; 125(4):402-4. PubMed ID: 21281536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intralesional cidofovir as adjuvant for the successful management of aggressive respiratory papillomatosis in an infant.
    Durvasula VS; Richter GT
    Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1912-5. PubMed ID: 24063771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of cidofovir for treatment of recurrent respiratory papillomatosis.
    Derkay C
    Arch Otolaryngol Head Neck Surg; 2009 Feb; 135(2):198-201. PubMed ID: 19221249
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of cidofovir on a novel cell-based test system for recurrent respiratory papillomatosis.
    Donne AJ; Hampson L; He XT; Rothera MP; Homer JJ; Hampson IN
    Head Neck; 2007 Aug; 29(8):741-50. PubMed ID: 17252592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant antiviral therapy for recurrent respiratory papillomatosis.
    Chadha NK; James A
    Cochrane Database Syst Rev; 2010 Jan; (1):CD005053. PubMed ID: 20091568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of cidofovir injection for the treatment of recurrent respiratory papillomatosis.
    Lee AS; Rosen CA
    J Voice; 2004 Dec; 18(4):551-6. PubMed ID: 15567056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stepped-dose protocol of cidofovir therapy in recurrent respiratory papillomatosis in children.
    Akst LM; Lee W; Discolo C; Knott D; Younes A; Koltai PJ
    Arch Otolaryngol Head Neck Surg; 2003 Aug; 129(8):841-6. PubMed ID: 12925342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.